Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R GONIN

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|March 1, 1995
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell supportA D Elias, L J Ayash, C Wheeler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemiaG Pichert, D C Roy, R Gonin, et al.
The Journal of Biological Chemistry|September 15, 1995
Interferon-inducible protein 10 and macrophage inflammatory protein-1 alpha inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell lineS M Aronica, C Mantel, R Gonin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapyI Tepler, S A Cannistra, E Frei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor responseL J Ayash, J E Wright, O Tretyakov, et al.
Blood|October 1, 1993
Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantationR J Soiffer, R Gonin, C Murray, et al.
American Journal of Clinical Oncology|February 1, 1994
Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term resultsA D Elias, A T Skarin, R Gonin, et al.
Cancer Gene Therapy|January 1, 1997
Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistanceS E Braun, R S McIvor, A S Davidson, et al.
The Journal of Infectious Diseases|June 1, 1994
Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulinG R Siber, D Leombruno, J Leszczynski, et al.
Journal of Surgical Oncology|October 1, 1987
Primate endocrine function after pancreatico-duodenal-splenic allotransplantationD F Du Toit, J J Heydenrych, B Smit, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|March 1, 1995
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell supportA D Elias, L J Ayash, C Wheeler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemiaG Pichert, D C Roy, R Gonin, et al.
The Journal of Biological Chemistry|September 15, 1995
Interferon-inducible protein 10 and macrophage inflammatory protein-1 alpha inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell lineS M Aronica, C Mantel, R Gonin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapyI Tepler, S A Cannistra, E Frei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor responseL J Ayash, J E Wright, O Tretyakov, et al.
Blood|October 1, 1993
Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantationR J Soiffer, R Gonin, C Murray, et al.
American Journal of Clinical Oncology|February 1, 1994
Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term resultsA D Elias, A T Skarin, R Gonin, et al.
Cancer Gene Therapy|January 1, 1997
Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistanceS E Braun, R S McIvor, A S Davidson, et al.
The Journal of Infectious Diseases|June 1, 1994
Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulinG R Siber, D Leombruno, J Leszczynski, et al.
Journal of Surgical Oncology|October 1, 1987
Primate endocrine function after pancreatico-duodenal-splenic allotransplantationD F Du Toit, J J Heydenrych, B Smit, et al.
Pageof 8